Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome

Clinical Reviews in Allergy and Immunology

Volumn 44, Issue 1, 2013, Pages 51-56

  Gualtierotti, Roberta ^a   Biggioggero, Martina ^a   Meroni, Pier Luigi ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Antiphospholipid syndrome; Arterial thrombosis; Atherosclerosis; Myocardial infarction

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; TICLOPIDINE; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CASE REPORT; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DIAGNOSTIC ERROR; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; PILL; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CORONARY ARTERY DISEASE; CORONARY DISEASE; FEMALE; HUMANS; MALE; MYOCARDIAL ISCHEMIA;

EID: 84872679411     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-011-8268-9     Document Type: Article

References (57)

1. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306
2. Hughes GR (2008) Hughes syndrome (the antiphospholipid syndrome): ten clinical lessons. Autoimmun Rev 7:262-266
3. Cervera R, Piette JC, Font J et al (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 46:1019-1027 (Pubitemid 34303815)
4. Cervera R, Khamashta MA, Shoenfeld Y et al (2009) Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 68:1428-1432
5. Font J, Cervera R (2006) Cardiac manifestations in antiphospholipid syndrome. In: Khamashta MA (ed) Hughes syndrome, 2nd edn. Springer, London, pp 41-53
6. Adler Y, Kinkelstein Y, Zanderman-Goddard G et al (1995) The presence of antiphospholipid antibodies in acute myocardial infarction. Lupus 4:309-313
7. Boekholdt SM, Kramer MHH (2007) Arterial thrombosis and the role of thrombophilia. Semin Thromb Hemost 33:588-596 (Pubitemid 47429311)
8. Vaarala O, Manttari M, Manninen V et al (1995) Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 91:23-27
9. 2-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction. Honol Heart Program Stroke 32:1701-1706 (Pubitemid 32772193)
10. Soltész P, Szekanecz Z, Kiss E, Shoenfeld Y (2007) Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev 6:379-386 (Pubitemid 46810399)
11. Vaarala O (1998) Antiphospholipid antibodies and myocardial infarction. Lupus 7:132-134
12. Hamsten A, Norberg R, Bjorkholm M et al (1986) Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet 1:113-116
13. Jalowiec DA, Hill JA (1989) Myocardial infarction in the young and in women. Cardiovasc Clin 20:197-206 (Pubitemid 19171268)
14. Zimmerman FH, Cameron A, Fisher LD, Ng G (1995) Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 26:654-661
15. Chen L, Chester M, Kaski JC (1995) Clinical factors and angiographic features associated with premature coronary artery disease. Chest 108:364-369
16. Kanitz MG, Giovannucci SJ, Jones JS, Mott M (1996) Myocardial infarction in young adults: risk factors and clinical features. J Emerg Med 14:139-145 (Pubitemid 26140778)
17. Stamler J, Stamler R, Neaton JD et al (1999) Low risk factor profile and long-term cardiovascular and non-cardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 282:2012-2018
18. Choudhury L, Marsh JD (1999) Myocardial infarction in young patients. Am J Med 107:254-261 (Pubitemid 29421592)
19. Osula S, Bell GM, Hornung RS (2002) Acute myocardial infarction in young adults: causes and management. Postgrad Med J 78:27-30 (Pubitemid 34074911)
20. Meroni PL, Peyvandi F, Foco L, on behalf of the Atherosclerosis, Thrombosis and Vascular Biology Italian Study Group et al (2007) Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women. J Thromb Haemost 5:2421-2428 (Pubitemid 350154352)
21. Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A (2009) Antiphospholipid antibodies and risk of myocardial infarction and ischemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 8:998-1005
22. Veres K, Lakos G, Kerényi A et al (2004) Antiphospholipid antibodies in acute coronary syndrome. Lupus 13:423-427 (Pubitemid 38931773)
23. Sweiss NJ, Bo R, Kapadia R et al (2010) IgA Anti-b2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus. PLoS ONE 5:e12280
24. Espinosa G, Cervera R (2009) Morbidity and mortality in the antiphospholipid syndrome. Curr Opin Pulm Med 15:413-417
25. Sangle SR, D'Cruz DP (2008) Syndrome X (angina pectoris with normal coronary arteries) and myocardial infarction in patients with antiphospholipid (Hughes) syndrome. Lupus 17:83-85 (Pubitemid 351346439)
26. Saponjski J, Stojanovich L, Djokovic A, Petkovic M, Mrda D (2011) Systemic vascular diseases in the antiphospholipid syndrome. What is the best diagnostic choice? Autoimmun Rev 10(4):235-237
27. Giannakopoulos B, Passam F, Rahgozar S, Krilis SA (2007) Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 109:422-430 (Pubitemid 46105935)
28. Pierangeli SS, Chen PP, Raschi E et al (2008) Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost 34:236-250
29. Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL (2006) Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 65:2-6 (Pubitemid 41815631)
30. Asherson RA, Cervera R (2003) Unusual manifestations of the antiphospholipid syndrome. Clin Rev Allergy Immunol 25:61-78 (Pubitemid 36819444)
31. Amigo MC (2007) The heart and APS. Clin Rev Allergy Immunol 32:178-183 (Pubitemid 47571443)
32. Zinger H, Sherer Y, Shoenfeld Y (2009) Atherosclerosis in autoimmune rheumatic diseases - mechanisms and clinical findings. Clin Rev Allergy Immunol 37:20-28
33. Bilora F, Boccioletti V, Girolami B et al (2002) Are antiphospholipid antibodies an independent risk factor for atherosclerosis? Clin Appl Thromb Hemost 8:103-113 (Pubitemid 34779129)
34. Medina G, Casaos D, Jara LJ et al (2003) Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis 62:607-610 (Pubitemid 36760555)
35. Mukherjee D, Hsu A, Moliterno DJ, Lincoff AM, Goormastic M, Topol EJ (2003) Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularization in patients < or = 40 years old. Am J Cardiol 92:1465-1467 (Pubitemid 37532575)
36. Ames PR, Margarita A, Sokoll KB, Weston M, Brancaccio V (2005) Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis 64:315-317 (Pubitemid 40193636)
37. Jiménez S, García-Criado MA, Tàssies D et al (2005) Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology 44:756-761 (Pubitemid 41487204)
38. Belizna CC, Richard V, Thuillez C, Levesque H, Shoenfeld Y (2007) Insights into atherosclerosis therapy in antiphospholipid syndrome. Autoimmun Rev 7:46-51 (Pubitemid 47633391)
39. Margarita A, Batuca J, Scenna G et al (2007) Subclinical atherosclerosis in primary antiphospholipid syndrome. Ann NY Acad Sci 108:475-480 (Pubitemid 47528761)
40. Der H, Kerekes G, Veres K et al (2007) Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome. Lupus 16:497-503 (Pubitemid 47242523)
41. Bassi N, Ghirardello A, Iaccarino L et al (2007) OxLDL/beta2GPI-anti- oxLDL/beta2GPI complex and atherosclerosis in SLE patients. Autoimmun Rev 7:52-58 (Pubitemid 47633392)
42. Belizna CC, Richard V, Primard E et al (2008) Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding. Semin Arthritis Rheum 37:373-380 (Pubitemid 351734519)
43. Ames PR, Margarita A, Alves JD (2009) Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome. Clin Rev Allergy Immunol 37:29-35
44. Cugno M, Borghi MO, Lonati LM et al (2010) Patients with antiphospholipid syndrome display endothelial perturbation. J Autoimmun 34:105-110
45. Asanuma Y, Oeser A, Shintani AK et al (2003) Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Eng J Med 349:2407-2415 (Pubitemid 37542989)
46. Roman MJ, Shanker BA, Davis A et al (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349:2399-2406 (Pubitemid 37542988)
47. Ohlenschlaeger T, Garred P, Madsen HO, Jacobsen S (2004) Mannose binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 351:260-267 (Pubitemid 38916043)
48. Petri M (2004) The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort. Thromb Res 114:593-595 (Pubitemid 39422596)
49. Farzaneh-Far A, Roman MJ, Lockshin MD et al (2006) Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum 54:3918-3925 (Pubitemid 44955895)
50. Hollan I, Mikkelsen K, Førre OT et al (2011) Antiphospholipid antibodies in rheumatic and non-rheumatic patients with coronary artery disease. First International Congress on Controversies in Rheumatology and Autoimmunity, Florence 10-12 March 2011, Abstract
51. Ruiz-Irastorza G, Hunt BJ, Khamashta MA (2007) A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis Rheum 57:1487-1495 (Pubitemid 350308848)
52. Ho YL, Chen MF, Wu CC et al (1996) Successful treatment of acute myocardial infarction by thrombolytic therapy in a patient with primary antiphospholipid antibody syndrome. Cardiology 87:354-357
53. Takeuchi S, Obayashi T, Toyama J (1998) Primary antiphospholipid syndrome with acute myocardial infarction recanalised by PTCA. Heart 79:96-98 (Pubitemid 28179073)
54. Morgan-Hughes G (2002) Acute myocardial infarction in young adults. Postgrad Med J 78:381
55. Davies JOJ, Hunt BJ (2007) Myocardial infarction in young patients without coronary atherosclerosis: assume primary antiphospholipid syndrome until proved otherwise. Int J Clin Pract 61:379-384
56. Tuthill JI, Khamashta MA (2009) Management of antiphospholipid syndrome. J Autoimmun 33:92-98
57. Ruiz-Irastorza G, Khamashta MA (2007) The treatment of antiphospholipid syndrome: a harmonic contrast. Best Pract Res Clin Rheum 21:1079-1092 (Pubitemid 350194042)